DEFERIPRONE - Meklēšanas rezultāti

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

ferriprox

chiesi new zealand limited t/a emerge health - deferiprone 500mg; - film coated tablet - 500 mg - active: deferiprone 500mg excipient: colloidal silicon dioxide hypromellose macrogol 3350 magnesium stearate microcrystalline cellulose titanium dioxide - ferriprox is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy or in whom desferrioxamine therapy has proven ineffective.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

ferriprox

chiesi new zealand limited t/a emerge health - deferiprone 100 mg/ml; - oral solution - 100 mg/ml - active: deferiprone 100 mg/ml excipient: cherry flavour 33.12676 glycerol hydrochloric acid hyetellose peppermint oil purified water sucralose sunset yellow fcf - ferriprox is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy or in whom desferrioxamine therapy has proven ineffective.